MX2019013799A - Peptido novedoso y composicion farmaceutica para tratar una enfermedad ocular que comprende el mismo como un ingrediente farmaceutico activo. - Google Patents
Peptido novedoso y composicion farmaceutica para tratar una enfermedad ocular que comprende el mismo como un ingrediente farmaceutico activo.Info
- Publication number
- MX2019013799A MX2019013799A MX2019013799A MX2019013799A MX2019013799A MX 2019013799 A MX2019013799 A MX 2019013799A MX 2019013799 A MX2019013799 A MX 2019013799A MX 2019013799 A MX2019013799 A MX 2019013799A MX 2019013799 A MX2019013799 A MX 2019013799A
- Authority
- MX
- Mexico
- Prior art keywords
- novel peptide
- pharmaceutical composition
- treatment
- active ingredient
- eye diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20170061250 | 2017-05-17 | ||
| PCT/KR2018/005673 WO2018225961A1 (ko) | 2017-05-17 | 2018-05-17 | 신규한 펩타이드 및 이를 유효성분으로 포함하는 안구질환 치료용 약학 조성물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019013799A true MX2019013799A (es) | 2020-08-13 |
Family
ID=64566301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019013799A MX2019013799A (es) | 2017-05-17 | 2018-05-17 | Peptido novedoso y composicion farmaceutica para tratar una enfermedad ocular que comprende el mismo como un ingrediente farmaceutico activo. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12037415B2 (enExample) |
| EP (1) | EP3643723B1 (enExample) |
| JP (2) | JP7680824B2 (enExample) |
| KR (2) | KR102287226B1 (enExample) |
| CN (1) | CN110945012A (enExample) |
| AU (1) | AU2018281617B2 (enExample) |
| BR (1) | BR112019024040A2 (enExample) |
| CA (1) | CA3063842A1 (enExample) |
| ES (1) | ES2982308T3 (enExample) |
| MX (1) | MX2019013799A (enExample) |
| RU (1) | RU2766160C2 (enExample) |
| SG (1) | SG11201912110YA (enExample) |
| WO (1) | WO2018225961A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12037415B2 (en) * | 2017-05-17 | 2024-07-16 | Yuyu Pharma, Inc. | Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient |
| TWI865470B (zh) * | 2018-11-14 | 2024-12-11 | 南韓商柳柳製藥股份有限公司 | 治療眼睛疾病之肽及醫藥組合物 |
| US11613558B2 (en) | 2018-11-14 | 2023-03-28 | Yuyu Pharma, Inc. | Peptides and pharmaceutical compositions for treating eye diseases |
| BR112021023477A2 (pt) * | 2019-05-21 | 2022-02-15 | Eyebio Korea | Novo composto peptídico, composição farmacêutica para prevenir ou tratar inflamação, composição de alimento para prevenir ou amenizar a inflamação e composição de cosmético tendo um efeito anti inflamatório |
| KR20210104460A (ko) * | 2020-02-17 | 2021-08-25 | 주식회사 아이바이오코리아 | 고체상 합성법을 이용한 펩타이드의 제조 방법 |
| WO2021191689A2 (en) * | 2020-03-05 | 2021-09-30 | Yuyu Pharma, Inc. | Treatment of inflammatory diseases with peptides and pharmaceutical compositions |
| MX2024006997A (es) * | 2021-12-13 | 2024-06-19 | Eyebiokorea Inc | Composicion para el tratamiento de la degeneracion macular que comprende un nuevo peptido. |
| KR102593936B1 (ko) * | 2021-12-13 | 2023-10-27 | 주식회사 아이바이오코리아 | 신규한 펩타이드를 포함하는 황반변성의 치료용 조성물 |
| KR102587729B1 (ko) * | 2023-02-27 | 2023-10-12 | 주식회사 아이바이오코리아 | 펩타이드를 포함하는 당뇨망막병증의 치료용 조성물 |
| KR102673860B1 (ko) * | 2023-08-10 | 2024-06-12 | (주)케어젠 | 안구 건조증의 개선 활성을 갖는 펩타이드 및 이의 용도 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6037135A (en) * | 1992-08-07 | 2000-03-14 | Epimmune Inc. | Methods for making HLA binding peptides and their uses |
| WO2007117444A2 (en) * | 2006-03-31 | 2007-10-18 | Yinghe Hu | Protein detection by aptamers |
| WO2009039854A2 (en) | 2007-09-27 | 2009-04-02 | Dako Denmark A/S | Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics |
| US20090131303A1 (en) * | 2007-11-16 | 2009-05-21 | Bor-Shyue Hong | Methods and compositions for treating dry eye |
| JP4490498B2 (ja) * | 2008-09-30 | 2010-06-23 | 新田ゼラチン株式会社 | 疾病抑制剤 |
| UA113627C2 (xx) | 2011-05-27 | 2017-02-27 | Кристалічна форма циклоспорину a, фармацевтична композиція та спосіб лікування | |
| WO2013079213A1 (en) | 2011-11-30 | 2013-06-06 | Xigen Inflammation Ltd. | Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of dry eye syndrome |
| KR101438744B1 (ko) | 2012-08-02 | 2014-09-15 | 전남대학교산학협력단 | 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물 |
| KR101948156B1 (ko) | 2013-12-10 | 2019-02-14 | 인제대학교 산학협력단 | 알칼리 화상을 이용한 각막 혼탁증 동물모델 및 각막 혼탁증 예방 또는 치료용 약학조성물 |
| KR101555296B1 (ko) | 2013-12-10 | 2015-09-23 | 인제대학교 산학협력단 | 연골세포 유래 세포외 기질을 유효성분으로 함유하는 건성안 예방 또는 치료용 약학조성물 |
| KR101721059B1 (ko) | 2014-12-26 | 2017-03-30 | 주식회사 아이바이오코리아 | 안구 표면 질환 예방 또는 치료용 약학조성물 |
| KR101690539B1 (ko) | 2015-07-30 | 2016-12-29 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 약학조성물 |
| AU2016373364B2 (en) | 2015-12-14 | 2019-07-11 | Tsung-Chuan Ho | Short synthetic peptide and uses thereof |
| KR101798183B1 (ko) * | 2016-04-08 | 2017-11-15 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 약학조성물 |
| ES2822289T3 (es) | 2016-04-08 | 2021-04-30 | Eyebio Korea | Péptido a base de colágeno tipo II alfa-1 para su uso en el tratamiento de la degeneración macular |
| KR101795653B1 (ko) * | 2016-05-19 | 2017-11-09 | 인제대학교 산학협력단 | 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물 |
| KR20180074928A (ko) | 2016-12-26 | 2018-07-04 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 동물 의약품 조성물 |
| US12037415B2 (en) | 2017-05-17 | 2024-07-16 | Yuyu Pharma, Inc. | Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient |
| TWI865470B (zh) * | 2018-11-14 | 2024-12-11 | 南韓商柳柳製藥股份有限公司 | 治療眼睛疾病之肽及醫藥組合物 |
| US11613558B2 (en) | 2018-11-14 | 2023-03-28 | Yuyu Pharma, Inc. | Peptides and pharmaceutical compositions for treating eye diseases |
| WO2021191689A2 (en) * | 2020-03-05 | 2021-09-30 | Yuyu Pharma, Inc. | Treatment of inflammatory diseases with peptides and pharmaceutical compositions |
-
2018
- 2018-05-17 US US16/614,123 patent/US12037415B2/en active Active
- 2018-05-17 EP EP18812841.7A patent/EP3643723B1/en active Active
- 2018-05-17 SG SG11201912110YA patent/SG11201912110YA/en unknown
- 2018-05-17 WO PCT/KR2018/005673 patent/WO2018225961A1/ko not_active Ceased
- 2018-05-17 BR BR112019024040-3A patent/BR112019024040A2/pt unknown
- 2018-05-17 ES ES18812841T patent/ES2982308T3/es active Active
- 2018-05-17 CA CA3063842A patent/CA3063842A1/en active Pending
- 2018-05-17 JP JP2019563617A patent/JP7680824B2/ja active Active
- 2018-05-17 RU RU2019141646A patent/RU2766160C2/ru active
- 2018-05-17 AU AU2018281617A patent/AU2018281617B2/en active Active
- 2018-05-17 KR KR1020180056745A patent/KR102287226B1/ko active Active
- 2018-05-17 CN CN201880047540.1A patent/CN110945012A/zh active Pending
- 2018-05-17 MX MX2019013799A patent/MX2019013799A/es unknown
-
2021
- 2021-07-30 KR KR1020210100394A patent/KR102498428B1/ko active Active
-
2023
- 2023-04-05 JP JP2023061251A patent/JP7775250B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7680824B2 (ja) | 2025-05-21 |
| JP2023098936A (ja) | 2023-07-11 |
| BR112019024040A2 (pt) | 2020-09-24 |
| AU2018281617B2 (en) | 2022-06-30 |
| KR102498428B1 (ko) | 2023-02-20 |
| KR20210097670A (ko) | 2021-08-09 |
| EP3643723C0 (en) | 2024-05-15 |
| RU2019141646A (ru) | 2021-06-17 |
| JP7775250B2 (ja) | 2025-11-25 |
| EP3643723A1 (en) | 2020-04-29 |
| CN110945012A (zh) | 2020-03-31 |
| WO2018225961A1 (ko) | 2018-12-13 |
| US12037415B2 (en) | 2024-07-16 |
| EP3643723B1 (en) | 2024-05-15 |
| CA3063842A1 (en) | 2019-12-09 |
| AU2018281617A1 (en) | 2019-12-05 |
| KR102287226B1 (ko) | 2021-08-11 |
| EP3643723A4 (en) | 2021-03-31 |
| SG11201912110YA (en) | 2020-01-30 |
| US20210024577A1 (en) | 2021-01-28 |
| RU2766160C2 (ru) | 2022-02-08 |
| ES2982308T3 (es) | 2024-10-15 |
| RU2019141646A3 (enExample) | 2021-07-28 |
| KR20180126406A (ko) | 2018-11-27 |
| JP2020520372A (ja) | 2020-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2016014634A (es) | Compuestos para el tratamiento de enfermedades y trastornos oftalmicos. | |
| MX2020003534A (es) | Composiciones oftalmicas que comprenden latanoprost para usarse en el tratamiento de las enfermedades oculares. | |
| EP4566651A3 (en) | Ophthalmic delivery device | |
| PH12019500423A1 (en) | Pharmaceutical composition | |
| BR112017004727A2 (pt) | dispositivo para aplicação de agente terapêutico com agulha e cânula avançáveis | |
| WO2017158366A3 (en) | Ophthalmic delivery device and ophthalmic drug compositions | |
| PH12017501097A1 (en) | Sunitinib formulations and methods for use thereof in treatment of ocular disorders | |
| DOP2017000270A (es) | Composiciones farmacéuticas tópicas | |
| AR093247A1 (es) | Agente profilactico y/o terapeutico para sintomas conductuales y psicologicos asociados con la enfermedad neurodegenerativa o sintomas impulsivos asociados con enfermedad mental que contiene brexpiprazol o sales del mismo | |
| EP4360709A3 (en) | Use of a vegf antagonist to treat angiogenic eye disorders | |
| WO2015095772A3 (en) | Formulations and methods for targeted ocular delivery of therapeutic agents | |
| MX2020006309A (es) | Fórmulaciones de parasiticida de isoxazolina y métodos para el tratamiento de la blefaritis. | |
| MX2018001918A (es) | Aplicación cuantitativa periorbital de farmacos oftalmologicos. | |
| MX2021005077A (es) | Peptidos y composiciones farmaceuticas para tratar enfermedades oculares. | |
| SG11201912110YA (en) | Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient | |
| MX2019015927A (es) | Composiciones para administración de fármacos y métodos de uso de las mismas. | |
| EA202191684A1 (ru) | Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии | |
| MX355853B (es) | Composicion oftalmica para el tratamiento de infeccion ocular. | |
| AR092842A1 (es) | Tratamiento de enfermedades inflamatorias oculares usando laquinimod | |
| WO2016060917A3 (en) | Formulations for histatin therapeutics | |
| BR112014009761B8 (pt) | Composição de reticulação melhorada entregue por iontoforese, útil para o tratamento de ceratocone | |
| CL2020001426A1 (es) | Composición tópica oftálmica que comprende ácido dobesilico para tratar enfermedades del segmento posterior del ojo. | |
| RU2014106328A (ru) | Фармацевтические композиции, содержащие 4-бром-n-(имидазолидин-2-илиден)-1н-бензимидазол-5-амин для лечения заболеваний сетчатки | |
| MX2022006523A (es) | Composicion que comprende budesonida para uso oftalmico. | |
| PH12017501796A1 (en) | Dry eye therapeutic agent comprising nandrolone or ester thereof or methenolone or ester thereof as an active ingredient |